HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.

Direct download: 076_-_Tardive_dyskinesia.mp3
Category:general -- posted at: 6:00am EST